Diagnostics Company Reports Market Research Reports & Industry Analysis
Diagnostics Company Reports Industry Research & Market Reports
-
Grifols SA (GRF) - Financial and Strategic SWOT Analysis Review
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More
-
Quest Diagnostics Inc (DGX) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
Cepheid Inc - Strategic SWOT Analysis Review
... employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope Business ... Read More
-
Quidel Corp (QDEL) - Financial and Strategic SWOT Analysis Review
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More
-
Diagnostic Medical Equipment Companies in China
... dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies ... Read More
-
Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022
... to the joint venture deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest joint venture agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully ... Read More
-
Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022
... of the latest option and evaluation agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of option and evaluation agreements from 2015 to 2022. There are two ... Read More
-
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2016-2022
... to the collaborative R&D deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest collaborative R&D deals announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully ... Read More
-
Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2016-2022
... to the licensing deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest licensing agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully up to ... Read More
-
Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2015-2022
... unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies. This report provides details of the latest co-promotion and co-marketing agreements announced in the pharmaceutical, biotechnology and diagnostic ... Read More
-
Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 to 2022
... how and why companies enter business, product, technology and royalty assets. The report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets. The focus of the ... Read More
-
Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 to 2022
... to the co-development deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest Co-development agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and ... Read More
-
Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2022
... of transactions, including the technology licensed, royalty rates, license fees, upfront and milestone payments. This report provides details of the latest partnering deals which disclose a royalty rate, announced in the pharmaceutical, biotechnology and diagnostic ... Read More
-
Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 to 2022
... agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of distribution agreements from 2015 to 2022. The report provides a detailed understanding and analysis of how and ... Read More
-
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022
... of the latest manufacturing and supply agreements announced in the pharmaceutical, biotechnology, device and diagnostic sectors. Fully revised and updated, the report provides details of manufacturing and supply agreements from 2015 to 2022. The report ... Read More
-
COVID-19 Testing Market Update, 2022
... occupy laboratories and the in vitro diagnostic (IVD) companies that serve them throughout 2021 and into 2022. Testing already present in large labs and clinics entered the home last year, which added to market revenues. ... Read More
-
Accelerate Diagnostics Inc (AXDX) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
Biotronik SE & Co KG - Strategic SWOT Analysis Review
... the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors ... Read More
-
F. Hoffmann-La Roche Ltd - Enterprise Tech Ecosystem Series
... oncology, immunology, neuroscience, ophthalmology, infectious diseases, respiratory, and other areas. The company also provides in-vitro diagnostics, tissue-based cancer diagnostics, and diabetes management solutions. The company offers its products and services to hospitals, commercial laboratories, healthcare ... Read More
-
Hologic Inc (HOLX) - Financial and Strategic SWOT Analysis Review
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More
-
Eurofins Scientific SE (ERF) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
Illumina Inc (ILMN) - Financial and Strategic SWOT Analysis Review
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More
-
Qiagen NV (QIA) - Financial and Strategic SWOT Analysis Review
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More
-
bioMerieux 2021: US, Europe, Japan - Market Shares by Test and Country, Competitive Position by Product
... includes diagnostics sales and market share estimates by product and country bioMerieux and its main competitors, as well as a profile of the company's diagnostics business. Please note: The delivery time for the electronic version ... Read More
-
DiaSorin 2021: US, Europe, Japan - Market Shares by Test and Country, Competitive Position by Product
... includes diagnostics sales and market share estimates by product and country for DiaSorin and its main competitors, as well as a profile of the company's diagnostics business. Please note: The delivery time for the electronic ... Read More
Research Assistance
